Send mail to Author

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus : a randomized, placebo-controlled phase II AIO trial with serum biomarker program (Article)

Please indicate your contact information and select, which author you want to contact.



 
           __   __    _  __   _    _     _  __   _    _   
  ____     \ \\/ //  | |/ // | || | ||  | |/ // | || | || 
 |    \\    \ ` //   | ' //  | || | ||  | ' //  | || | || 
 | [] ||     | ||    | . \\  | \\_/ ||  | . \\  | \\_/ || 
 |  __//     |_||    |_|\_\\  \____//   |_|\_\\  \____//  
 |_|`-`      `-`'    `-` --`   `---`    `-` --`   `---`   
 `-`
 


Back to frontdoor view

OPUS4 Logo